This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr. Barry Duplantis, PhD
Director of Global Business Development at Ailux Biologics by XtalPi
Speaker

Profile

Dr. Barry Duplantis has a strong technical background and over a decade of experience applying drug discovery and development platforms in commercial settings. He was the founder and CEO of a biotech startup and later led client relations at a global contract research organization. Dr. Duplantis earned his Ph.D. from the University of Victoria, where his research focused on intracellular pathogenesis and vaccine development.